Documents FDA-2010-N-0274-0021.1

Perspectives on Appropriateness for LDTs to be used as Companion Dx Assays Presented by: Eric Lawson Director, Regulatory Affairs Voisin Consulting Life Sciences Chairman,…

Documents 4th Kitasato-Harvard symposium on October 29, 2003 Japan Issues and Counter Measure for Real...

Slide 1 4th Kitasato-Harvard symposium on October 29, 2003 Japan Issues and Counter Measure for Real Implementation of Genome Based Clinical Trials Sanae Yasuda, PhD Eisai…

Documents PHARMACOGENOMICS

PHARMACOGENOMICS John N. van den Anker, MD, PhD, FCP, FAAP Children’s National Medical Center, Washington, DC, USA & Intensive Care, Erasmus MC-Sophia Children’s…

Documents Pharmacogenetics and respiratory disease

Pharmacogenetics and respiratory disease Genetic biomarkers for treatment of disease and targeting of treatments Dr John W Holloway Polymorphism in a gene either in a single…